BESTSOURCE
Dead / Abandoned — Abandoned — no statement of use filed (as of 18 Jan 2010)
What this means for you
This application is over — abandoned 18 Jan 2010. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78691632
- Mark type
- Design + words
- Filed
- 12 Aug 2005
- Published for opposition
- 26 Sept 2006
- Abandoned
- 18 Jan 2010
- Attorney of record
- KATHLEEN A. COSTIGAN,
Goods and services
- Class 005 — Pharmaceuticals: Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations namely, anticoagulants; Pharmaceutical preparations namely, antidepressants; Pharmaceutical preparations namely, appetite suppressants; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Vitamins
Owner
- Anda Marketing, Inc., Weston, FL, US
- Anda Marketing, Inc., Weston, FL, US
Prosecution history
- 19 Jan 2014 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 May 2010 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Jan 2010 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 18 Jan 2010 — ABANDONMENT - NO USE STATEMENT FILED
- 30 Jun 2009 — SOU EXTENSION 5 GRANTED
- 08 Jun 2009 — SOU EXTENSION 5 FILED
- 30 Jun 2009 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Jun 2009 — SOU TEAS EXTENSION RECEIVED
- 25 Nov 2008 — SOU EXTENSION 4 GRANTED
- 25 Nov 2008 — SOU EXTENSION 4 FILED
- 25 Nov 2008 — SOU TEAS EXTENSION RECEIVED
- 17 Jun 2008 — SOU EXTENSION 3 GRANTED
- 17 Jun 2008 — SOU EXTENSION 3 FILED
- 17 Jun 2008 — SOU TEAS EXTENSION RECEIVED
- 19 Dec 2007 — SOU EXTENSION 2 GRANTED